Upgrade to SI Premium - Free Trial

Lakewood-Amedex partners with PERI for Nu-3 phase 2 trial

May 12, 2026 8:02 AM
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced it has entered into an agreement with Professional Education and Research Institute LLC to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA